The Problem with Sepsis is…
Focusing on the Coda Sepsis agenda & drawing actions from WHO Sepsis Resolution, this panel session will combine sepsis survivors and families, clinicians and researchers to better define the human cost of sepsis. This session will formally launch the design thinking process towards community generated sepsis actions for Coda 2022.
Professor Carol Hodgson PhD FACP PT is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre at Monash University. She has developed and led international Phase II and III trials to test early interventions to improve long-term outcomes and the quality of survival.
She leads grants (> $15M) for international, randomised trials and a binational registry.
Her work as a specialist ICU physiotherapist leading clinical research in Australia and New Zealand has led to a paradigm shift in the treatment of ICU patients, especially rehabilitation practices.
She has over 100 publications in this field and experience developing international guidelines for mechanical ventilation, early mobilisation and the management of sepsis.@chodgsonANZICRC
Simon Finfer is a Pom who emigrated to Australia in 1993 to practice full time intensive care medicine. Despite being qualified 37 years and receiving an NHS pension he still works as a bedside clinician and takes night call. He loves his job because he works with fantastic people. He also designs and runs large clinical trials, writes paper, edits books and rides a 2017 Triumph Bonneville T120. He supports West Ham United and the English Cricket, Football and Rugby teams. He lives in Sydney with his wife, sons, two horses, four chickens, 3 ducks and one dog. Twitter handle is @icuresearch.@icuresearch
Ron Daniels is an NHS Consultant in Intensive Care, based in Birmingham, U.K. He’s also Executive Director of the UK Sepsis Trust and sits on the Executive Board of the Global Sepsis Alliance. In 2016 he was awarded the British Empire Medal for services to patients. Ron’s expertise lies in translational medicine and leadership. He leads the team driving dissemination of the Sepsis 6 treatment pathway and is part of the team responsible for much of the policy and media engagement around sepsis in the U.K. and elsewhere, including the adoption of the 2017 Resolution on Sepsis by the WHO. At home, Ron’s worked with the NHS over the last 5 years to ensure that, in England, more than 80% of patients presenting with suspected sepsis now receive appropriate antimicrobials rapidly. He’s ever mindful of the perceived conflict, and the synergies and need for collaboration, with the antimicrobial stewardship agenda.